NCT05724823 Virtual Physical Activity Seated Exercise - Phase 2
| NCT ID | NCT05724823 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-11 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-11 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment. Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.
Eligibility Criteria
Inclusion Criteria: Participants must meet the following inclusion criteria: * Adult (as defined by Province) * Chronic stroke (more than 6 months post-stroke) * Ability to stand up from a chair * Mobility impairment of lower extremity (requires a walking aid, with or without close supervision) * Able to safely engage in exercise and tolerate 60 minutes of exercises * Able to communicate in English * Have access to a tablet, computer, or laptop with internet and email access Exclusion Criteria: Participants will be excluded if they meet any of the following criteria: * Participating in formal exercise or rehabilitation activities * Participating in \> 30 minutes/day of physical activity (moderate intensity) * Participating in another study that may affect outcomes to this study * Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software * A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer) * Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05724823 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05724823 currently recruiting?
Yes, NCT05724823 is actively recruiting participants. Contact the research team at chihya.hung@ubc.ca for enrollment information.
Where is the NCT05724823 trial being conducted?
This trial is being conducted at Vancouver, Canada, Winnipeg, Canada, Halifax, Canada, London, Canada and 1 additional location.
Who is sponsoring the NCT05724823 clinical trial?
NCT05724823 is sponsored by University of British Columbia. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.